Molecular and clinical characteristics of very long-chain acyl-CoA dehydrogenase deficiency

References

1. ↵
   1. Leslie ND,
   2. Valencia CA,
   3. Strauss AW,
   4. Connor JA,
   5. Zhang K,
   6. Ardinger HH,
   7. et al.

   (1993-2020) GeneReviews®[Internet], Very long-chain acyl-Coenzyme A dehydrogenase deficiency (University of Washington, Seattle, Seattle (WA)).
2. ↵
   1. Alfadhel M,
   2. Benmeakel M,
   3. Hossain MA,
   4. Al Mutairi F,
   5. Al Othaim A,
   6. Alfares AA,
   7. et al.

   (2016) Thirteen-year retrospective review of the spectrum of inborn errors of metabolism presenting in a tertiary center in Saudi Arabia. Orphanet J Rare Dis 11:126.

   OpenUrl
3. ↵
   1. Wilcken B

   (2010) Fatty acid oxidation disorders:Outcome and long-term prognosis. J Inherit Metab Dis 33:501–506.

   OpenUrlCrossRefPubMed
4. ↵
   1. Andresen BS,
   2. Olpin S,
   3. Poorthuis BJ,
   4. Scholte HR,
   5. Vianey-Saban C,
   6. Wanders R,
   7. et al.

   (1999) Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency. Am J Hum Genet 64:479–494.

   OpenUrlCrossRefPubMedWeb of Science
5. ↵
   1. Pena LD,
   2. van Calcar SC,
   3. Hansen J,
   4. Edick MJ,
   5. Walsh Vockley C,
   6. Leslie N,
   7. et al.

   (2016) Outcomes and genotype-phenotype correlations in 52 individuals with VLCAD deficiency diagnosed by NBS and enrolled in the IBEM-IS database. Mol Genet Metab 118:272–281.

   OpenUrl
6. ↵
   1. Miller MJ,
   2. Burrage LC,
   3. Gibson JB,
   4. Strenk ME,
   5. Lose EJ,
   6. Bick DP,
   7. et al.

   (2015) Recurrent ACADVL molecular findings in individuals with a positive newborn screen for very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency in the United States. Mol Genet Metab 116:139–145.

   OpenUrlCrossRef
7. ↵
   1. Lindner M,
   2. Hoffmann GF,
   3. Matern D

   (2010) NBS for disorders of fatty-acid oxidation:experience and recommendations from an expert meeting. J Inherit Metab Dis 33:521–526.

   OpenUrlCrossRefPubMed
8. ↵
   1. Merritt JL,
   2. Vedal S,
   3. Abdenur JE,
   4. Au SM,
   5. Barshop BA,
   6. Feuchtbaum L,
   7. Harding CO,
   8. Hermerath C,
   9. Lorey F,
   10. Sesser DE,
   11. Thompson JD,
   12. Yu A

   (2014) Infants suspected to have very-long-chain acyl-CoA dehydrogenase deficiency from newborn screening. Mol Genet Metab 111:484–492.

   OpenUrl
9. ↵
   1. Evans M,
   2. Andresen BS,
   3. Nation J,
   4. Boneh A

   (2016) VLCAD deficiency:Follow-up and outcome of patients diagnosed through newborn screening in Victoria. Mol Genet Metab 118:282–287.

   OpenUrl
10. ↵
    1. Obaid A,
    2. Nashabat M,
    3. Alfadhl M,
    4. et al.

    (2017) Clinical, biochemical, and molecular features in 37 Saudi patients with very long- chain acyl- CoA dehydrogenase deficiency. J Inherit Metab Dis 40:47–53.

    OpenUrl
11. 1. Watanabe H,
    2. Orii KE,
    3. Fukao T,
    4. Song XQ,
    5. Aoyama T,
    6. IJlst L,
    7. et al.

    (2000) Molecular basis of very long chain acyl-CoA dehydrogenase deficiency in three Israeli patients:identification of a complex mutant allele with P65L and K247Q mutations, the former being an exonic mutation causing exon 3 skipping. Hum Mutat 15:430–438.

    OpenUrlCrossRefPubMed
12. 1. Andresen BS,
    2. Bross P,
    3. Vianey-Saban C,
    4. et al.

    (1996) Cloning and characterization of human very-long-chain acyl-CoA dehydrogenase cDNA, chromosomal assignment of the gene and identification in four patients of nine different mutations within the VLCAD gene. Hum Mol Genet 5:461–472.

    OpenUrlCrossRefPubMedWeb of Science
13. 1. Souri M,
    2. Aoyama T,
    3. Hoganson G,
    4. Hashimoto T

    (1998) Very-long-chain acyl-CoA dehydrogenase subunit assembles to the dimer form on mitochondrial inner membrane. FEBS Lett 426:187–190.

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    1. Hisahara S,
    2. Matsushita T,
    3. Furuyama H,
    4. Tajima G,
    5. Shigematsu Y,
    6. Imai T,
    7. et al.

    (2015) A heterozygous missense mutation in adolescent-onset very long-chain acyl-CoA dehydrogenase deficiency with exercise-induced rhabdomyolysis. Tohoku J Exp Med 235:305–315.

    OpenUrlCrossRef
15. 1. Schiff M,
    2. Mohsen AW,
    3. Karunanidhi A,
    4. McCracken E,
    5. Yeasted R,
    6. Vockley J

    (2013) Molecular and cellular pathology of very-long-chain acyl-CoA dehydrogenase deficiency. Mol Genet Metab 109:21–27.

    OpenUrlCrossRefPubMed
16. ↵
    1. Isackson PJ,
    2. Sutton KA,
    3. Hostetler KY,
    4. et al.

    (2013) Novel mutations in the gene encoding very long-chain acyl-CoA dehydrogenase identified in patients with partial carnitine palmitoyltransferase II deficiency. Muscle Nerve 47:224–233.

    OpenUrlCrossRefPubMed